Diabetes Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Diabetes stocks.

Diabetes Stocks Recent News

Date Stock Title
May 10 APLT Applied Therapeutics Inc (APLT) Reports Q1 2024 Earnings: A Deep Dive into Financials and ...
May 10 BDX U.S. to issue new tariffs against Chinese-made medical supplies: Reuters
May 9 ABT Drugmaker Abbott India posts Q4 profit rise on higher sales
May 9 ABT Amazon, Abbott Laboratories And 2 Other Stocks Insiders Are Selling
May 9 ASND Latest Clinical and Quality-of-Life Data for TransCon™ PTH (Palopegteriparatide)-Treated Adults with Chronic Hypoparathyroidism to Be Presented at ECE 2024
May 9 APLT Applied Therapeutics GAAP EPS of -$0.67 misses by $0.51
May 9 APLT Applied Therapeutics Reports First Quarter 2024 Financial Results
May 9 ABT Insider Sale: Executive Vice President Lisa Earnhardt Sells 22,852 Shares of Abbott ...
May 8 AMED Amedisys gains amid report of sweetened divestiture offer in UnitedHealth deal
May 8 BLTE Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results
May 8 ABT Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
May 8 ASND An Update On Ascendis Pharma's Path To Profitability
May 8 ABT The Zacks Analyst Blog Highlights Tesla, Johnson & Johnson, Netflix, Abbott and ConocoPhillips
May 7 ABT 13 Best Stocks That Will Always Grow
May 7 APLT Applied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare Conference
May 6 BDX 11 Best Recession Dividend Stocks To Buy
May 6 ABT 11 Best Recession Dividend Stocks To Buy
May 6 ASND Ascendis Pharma A/S (NASDAQ:ASND) Q1 2024 Earnings Call Transcript
May 6 BLTE Belite Bio to Participate in Key Opinion Leader Webinar to Discuss Unmet Needs In Stargardt Disease (STGD1) and Geographic Atrophy (GA) and Perspectives On Tinlarebant
May 6 BLTE Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at the ARVO Annual Meeting
Diabetes

Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications. Acute complications can include diabetic ketoacidosis, hyperosmolar hyperglycemic state, or death. Serious long-term complications include cardiovascular disease, stroke, chronic kidney disease, foot ulcers, and damage to the eyes.Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. There are three main types of diabetes mellitus:
Type 1 DM results from the pancreas' failure to produce enough insulin due to loss of beta cells. This form was previously referred to as "insulin-dependent diabetes mellitus" (IDDM) or "juvenile diabetes". The cause is unknown.
Type 2 DM begins with insulin resistance, a condition in which cells fail to respond to insulin properly. As the disease progresses, a lack of insulin may also develop. This form was previously referred to as "non insulin-dependent diabetes mellitus" (NIDDM) or "adult-onset diabetes". The most common cause is a combination of excessive body weight and insufficient exercise.
Gestational diabetes is the third main form, and occurs when pregnant women without a previous history of diabetes develop high blood sugar levels.Prevention and treatment involve maintaining a healthy diet, regular physical exercise, a normal body weight, and avoiding use of tobacco. Control of blood pressure and maintaining proper foot care are important for people with the disease. Type 1 DM must be managed with insulin injections. Type 2 DM may be treated with medications with or without insulin. Insulin and some oral medications can cause low blood sugar. Weight loss surgery in those with obesity is sometimes an effective measure in those with type 2 DM. Gestational diabetes usually resolves after the birth of the baby.As of 2015, an estimated 415 million people had diabetes worldwide, with type 2 DM making up about 90% of the cases. This represents 8.3% of the adult population, with equal rates in both women and men. As of 2014, trends suggested the rate would continue to rise. Diabetes at least doubles a person's risk of early death. From 2012 to 2015, approximately 1.5 to 5.0 million deaths each year resulted from diabetes. The global economic cost of diabetes in 2014 was estimated to be US$612 billion. In the United States, diabetes cost $245 billion in 2012.

Browse All Tags